scispace - formally typeset
N

Nathan Pankratz

Researcher at University of Minnesota

Publications -  207
Citations -  14743

Nathan Pankratz is an academic researcher from University of Minnesota. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 52, co-authored 168 publications receiving 10932 citations. Previous affiliations of Nathan Pankratz include Indiana University – Purdue University Indianapolis & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

TL;DR: This article conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls.
Journal ArticleDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

Daniel Taliun, +205 more
- 10 Feb 2021 - 
TL;DR: The Trans-Omics for Precision Medicine (TOPMed) project as discussed by the authors aims to elucidate the genetic architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of improving diagnosis, treatment and prevention of these diseases.
Posted ContentDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Daniel Taliun, +194 more
- 06 Mar 2019 - 
TL;DR: The nearly complete catalog of genetic variation in TOPMed studies provides unique opportunities for exploring the contributions of rare and non-coding sequence variants to phenotypic variation as well as resources and early insights from the sequence data.
Journal ArticleDOI

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database.

Christina M. Lill, +62 more
- 15 Mar 2012 - 
TL;DR: This study provides an exhaustive and up-to-date summary of the status of PD genetics research that can be readily scaled to include the results of future large-scale genetics projects, including next-generation sequencing studies.